The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
109550524 10955052 4 F 2011 20160425 20150325 20160728 EXP JP-009507513-1503JPN000143 MERCK 60.00 YR F Y 43.00000 KG 20160728 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
109550524 10955052 1 PS PEGINTRON PEGINTERFERON ALFA-2B 1 Subcutaneous 70 MICROGRAM, WEEKLY 103949 70 UG POWDER FOR INJECTION /wk
109550524 10955052 2 SS RIBAVIRIN. RIBAVIRIN 1 Oral 400 MG, QD U 0 400 MG CAPSULE QD
109550524 10955052 3 SS RIBAVIRIN. RIBAVIRIN 1 Oral 400 UNK, UNK U 0 400 MG CAPSULE QD
109550524 10955052 4 SS RIBAVIRIN. RIBAVIRIN 1 Oral 400 MG, QD U 0 400 MG CAPSULE QD
109550524 10955052 5 SS REBETOL RIBAVIRIN 1 Oral 400 MG, QD 0 400 MG CAPSULE QD
109550524 10955052 6 SS PREDNISOLONE. PREDNISOLONE 1 UNK U 0 SUSPENSION FOR INJECTION
109550524 10955052 7 SS FERON INTERFERON BETA 1 Intravenous (not otherwise specified) 6 (MILLION-BILLION UNIT), QD 0 INJECTION QD
109550524 10955052 8 SS FERON INTERFERON BETA 1 Intravenous (not otherwise specified) 6 (MILLION-BILLION UNIT), QD U 0 INJECTION QD
109550524 10955052 9 SS TACROLIMUS. TACROLIMUS 1 Oral DAILY DOSE UNKNOWN (FORMULATION: POR) U 0
109550524 10955052 10 SS CYCLOSPORINE. CYCLOSPORINE 1 Oral DAILY DOSE UNNOWN U 0 CAPSULE
109550524 10955052 11 C MITIGLINIDE CALCIUM HYDRATE MITIGLINIDE CALCIUM HYDRATE 1 Oral DAILY DOSAGE UNKNOWN, IMMEDIATELY BEFORE MEAL 0 TABLET
109550524 10955052 12 C INSULIN ASPART INSULIN ASPART 1 Parenteral 4 DF, TID (4 DOSE UNDER 1000UNITS) 0 4 DF INJECTION TID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
109550524 10955052 1 Hepatitis C
109550524 10955052 2 Hepatitis C
109550524 10955052 3 Hepatitis C RNA positive
109550524 10955052 4 Hepatitis C RNA positive
109550524 10955052 5 Hepatitis C
109550524 10955052 6 Immunosuppression
109550524 10955052 7 Hepatitis C
109550524 10955052 8 Hepatitis C RNA positive
109550524 10955052 9 Immunosuppressant drug therapy
109550524 10955052 10 Immunosuppressant drug therapy
109550524 10955052 11 Diabetes mellitus
109550524 10955052 12 Diabetes mellitus

Outcome of event

Event ID CASEID OUTC COD
109550524 10955052 OT
109550524 10955052 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
109550524 10955052 Liver disorder
109550524 10955052 Post procedural infection
109550524 10955052 Procalcitonin increased
109550524 10955052 Renal impairment
109550524 10955052 Shock

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
109550524 10955052 1 2010 0
109550524 10955052 2 201004 0
109550524 10955052 3 201012 0
109550524 10955052 4 201012 0
109550524 10955052 5 2010 0
109550524 10955052 6 2010 0
109550524 10955052 7 201004 0
109550524 10955052 8 201012 0
109550524 10955052 9 2010 201012 0
109550524 10955052 10 201012 0